Section Arrow
WAT.NYSE
- Waters Corp
Quotes are at least 15-min delayed:2026/01/06 18:54 EST
After Hours
Last
 400.24
-0.3 (-0.07%)
Bid
390
Ask
409
High 400.54 
Low 394.66 
Volume 19.66K 
Regular Hours (Closed)
Last
 400.54
+5.57 (+1.41%)
Day High 
408.67 
Prev. Close
394.97 
1-M High
397.55 
Volume 
466.11K 
Bid
390
Ask
409
Day Low
394.38 
Open
394.38 
1-M Low
372.17 
Market Cap 
23.52B 
Currency 美元 
P/E 36.3 
%Yield -- 
10-SMA 384.21 
20-SMA 385.33 
50-SMA 380.17 
52-W High 423.56 
52-W Low 275.05 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
10.88/15.16
Enterprise Value
25.20B
Balance Sheet
Book Value Per Share
39.14
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
2.96B
Operating Revenue Per Share
50.30
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp7.41+0.15+2.07%879PE
After Hours 7.49 +0.08 +1.08%
GHGuardant Health112.33+10.46+10.27%-- 
After Hours 113 +0.67 +0.60%
EXASExact Sciences Corp101.65+0.04+0.04%-- 
After Hours 101.65 0 0.00%
OPKOPKO Health1.32+0.04+3.13%-- 
After Hours 1.32 0 0.00%
DHRDanaher Corp236.59+1.23+0.52%48.43PE
After Hours 236.32 -0.27 -0.11%
Industry overview quotes are at least 15 minutes delayed
Business Description
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.